Satoshi Gando Selected Research

Protein Isoforms (Isoforms)

4/2007	Differential expression, time course and distribution of four PARs in rats with endotoxin-induced acute lung injury.
12/2006	Chronological expression of PAR isoforms in acute liver injury and its amelioration by PAR2 blockade in a rat model of sepsis.
10/2003	Contractions to histamine in pulmonary and mesenteric arteries from endotoxemic rabbits: modulation by vascular expressions of inducible nitric-oxide synthase and histamine H1-receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoshi Gando Research Topics

Disease

76	Disseminated Intravascular Coagulation 05/2024 - 01/2003
62	Sepsis (Septicemia) 05/2024 - 08/2002
33	Thrombosis (Thrombus) 10/2023 - 12/2002
33	Wounds and Injuries (Trauma) 10/2023 - 12/2002
23	Multiple Organ Failure (MODS) 01/2022 - 08/2002
22	Inflammation (Inflammations) 10/2023 - 12/2002
21	Hemorrhage 10/2023 - 04/2005
18	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 05/2024 - 08/2002
14	Critical Illness (Critically Ill) 02/2016 - 10/2003
12	Shock 01/2022 - 10/2003
10	Infections 12/2023 - 01/2005
10	Septic Shock (Toxic Shock Syndrome) 11/2020 - 08/2002
9	Heart Arrest (Cardiac Arrest) 01/2022 - 05/2008
7	Out-of-Hospital Cardiac Arrest 01/2021 - 05/2008
7	Acute Lung Injury 01/2020 - 11/2004
6	Hypoxia (Hypoxemia) 10/2023 - 07/2011
6	Endotoxemia 09/2006 - 12/2002
5	Hypothermia 05/2020 - 11/2013
5	Hypotension (Low Blood Pressure) 10/2017 - 12/2002
4	COVID-19 01/2022 - 01/2020
4	Post-Cardiac Arrest Syndrome 01/2022 - 07/2013
3	Neoplasms (Cancer) 10/2023 - 06/2011
3	Body Weight (Weight, Body) 05/2015 - 12/2008
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2013 - 01/2003
2	Thrombocytopenia (Thrombopenia) 11/2023 - 10/2007
2	Thromboinflammation 01/2022 - 01/2021
2	Lung Injury 01/2022 - 01/2010
2	Frailty 08/2021 - 01/2021
2	Heart Failure 01/2020 - 02/2016
2	Acidosis 03/2016 - 02/2015
1	Hyperoxia 12/2023

Drug/Important Bio-Agent (IBA)

76	Dacarbazine (DIC)FDA LinkGeneric 05/2024 - 08/2002
20	FibrinIBA 10/2023 - 01/2007
16	AntithrombinsIBA 01/2022 - 12/2006
13	AnticoagulantsIBA 05/2024 - 02/2006
13	Thrombin FDA Link 10/2023 - 07/2011
11	ThrombomodulinIBA 01/2022 - 12/2002
11	Leukocyte Elastase (Neutrophil Elastase)IBA 07/2013 - 08/2002
9	Plasminogen Activators (Plasminogen Activator)IBA 10/2023 - 01/2007
8	Fibrinogen (Factor I)FDA Link 09/2019 - 12/2006
8	Hemostatics (Antihemorrhagics)IBA 03/2016 - 12/2003
7	Proteinase-Activated ReceptorsIBA 10/2023 - 11/2004
7	Thromboplastin (Tissue Factor)IBA 10/2023 - 08/2002
7	Protein CIBA 12/2018 - 12/2003
6	Fibrinolysin FDA Link 10/2023 - 01/2007
6	estropipate (Ogen)FDA LinkGeneric 08/2022 - 07/2011
6	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2007
6	Fibrin Fibrinogen Degradation ProductsIBA 08/2017 - 01/2007
5	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 02/2011
5	EndotoxinsIBA 11/2020 - 10/2003
5	Anti-Bacterial Agents (Antibiotics)IBA 03/2020 - 06/2010
5	formycin diphosphate (FDP)IBA 08/2017 - 01/2007
5	Vasoconstrictor AgentsIBA 05/2014 - 10/2003
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2007
4	CytokinesIBA 01/2021 - 02/2010
4	Peptides (Polypeptides)IBA 05/2014 - 12/2006
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2013 - 06/2006
4	LipopolysaccharidesIBA 04/2007 - 12/2002
3	Histones (Histone)IBA 10/2023 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 04/2007
3	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2023 - 02/2011
3	Tranexamic Acid (AMCA)FDA Link 08/2022 - 03/2011
3	Angiotensin IIIBA 01/2022 - 09/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2015
3	Complement System Proteins (Complement)IBA 01/2021 - 11/2017
3	Heparin (Liquaemin)FDA LinkGeneric 01/2020 - 01/2014
3	Epinephrine (Adrenaline)FDA LinkGeneric 01/2019 - 01/2013
3	Endothelins (Endothelin)IBA 05/2014 - 09/2006
3	Antifibrinolytic Agents (Antifibrinolytics)IBA 07/2011 - 11/2009
3	Antithrombin IIIIBA 10/2009 - 12/2006
3	Protein Isoforms (Isoforms)IBA 04/2007 - 10/2003
3	Histamine (Histamine Dihydrochloride)FDA Link 04/2005 - 12/2002
2	Oxygen (Dioxygen)IBA 12/2023 - 10/2023
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 01/2015
2	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 12/2012 - 02/2011
2	Macrophage Migration-Inhibitory FactorsIBA 06/2011 - 08/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008 - 08/2007
2	urinastatin (MR 20)IBA 05/2008 - 01/2007
2	Plasminogen Activator Inhibitor 1IBA 01/2007 - 11/2004
2	Nitric Oxide Synthase (NO Synthase)IBA 06/2006 - 10/2003
2	OligodeoxyribonucleotidesIBA 04/2005 - 12/2004
2	NF-kappa B (NF-kB)IBA 04/2005 - 12/2004
2	NF-kappaB decoyIBA 04/2005 - 12/2004
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2005 - 12/2002
2	SelectinsIBA 01/2005 - 12/2002
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2005 - 12/2002
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2003 - 08/2002

Therapy/Procedure

16	Therapeutics 05/2024 - 01/2010
9	Critical Care (Surgical Intensive Care) 12/2023 - 01/2008
9	Resuscitation 01/2022 - 09/2012
4	Cardiopulmonary Resuscitation (CPR) 01/2016 - 05/2009
3	Blood Transfusion (Blood Transfusions) 08/2022 - 01/2010
3	Patient Care Bundles 01/2022 - 11/2019
3	Extracorporeal Membrane Oxygenation 01/2022 - 02/2016
3	Artificial Respiration (Mechanical Ventilation) 01/2022 - 08/2013
3	Hemodiafiltration 01/2015 - 10/2003
2	Glycemic Control 10/2021 - 02/2014
2	Length of Stay 08/2021 - 01/2021
2	Catheters 01/2016 - 10/2005
2	Continuous Renal Replacement Therapy 05/2009 - 07/2006